However, our results indicate that the inhibition of PMAT/OCT3 did not change the rate of accumulation of 5‐HT during ischemia and suggests that PMAT/OCT3 was not contributing to the clearance of 5‐HT during ischemia. This evidence concerns the gene SLC22A3 and ischemia.